Risk vs. benefit: Standard treatment for hepatitis c has been with peginterferon and ribavirin. Response rates varied depending on the type of hep c virus (called genotype). There are new medications boceprevir and telaprevir which have improved response to treatment. The decision to undergo treatment again depends on a risk vs benefit discussion between your mom and her doctor. Try to be supportive. She needs you.
Answered 9/2/2013
5.3k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
2 doctors weighed in across 2 answers
7 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question